Restasis 0.05 % Ophthalmic Emulsion
RxNorm 402092
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 402092 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Restasis 0.05 % Ophthalmic Emulsion.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Cyclosporine 0.5 mg/ML Ophthalmic Suspension [Restasis]
(Atom ID: 12357120)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
CycloSPORINE 0.5 mg/ML Ophthalmic Suspension [Restasis]
(Atom ID: 3737234)
PSNPrescribable
Prescribable Name (PSN):
Restasis 0.05 % Ophthalmic Emulsion
(Atom ID: 6403639)
SYPrescribable
Synonym (SY):
Restasis 0.05 % Ophthalmic Emulsion
(Atom ID: 6407815)
SYPrescribable
Synonym (SY):
Restasis 0.05 % Ophthalmic Suspension
(Atom ID: 3041627)
SYPrescribable
Synonym (SY):
Restasis 0.5 mg/ML Ophthalmic Suspension
(Atom ID: 1660658)
Patient Education
Cyclosporine Ophthalmic
Ophthalmic cyclosporine is used to increase tear production in people with dry eye disease. Cyclosporine is in a class of medications called immunomodulators. It works by decreasing swelling in the eye to allow for tear production.
[Learn More]
* Please review the disclaimer below.